Anthracycline-induced cardiotoxicity (ACT) is a key limiting factor in setting optimal chemotherapy regimes, with almost half of patients expected to develop congestive heart failure given high doses. However, the genetic basis of sensitivity to anthracyclines remains unclear. We created a panel of iPSC-derived cardiomyocytes from 45 individuals and performed RNA-seq after 24h exposure to varying doxorubicin dosages. The transcriptomic response is substantial: the majority of genes are differentially expressed and over 6000 genes show evidence of differential splicing, the later driven by reduced splicing fidelity in the presence of doxorubicin. We show that inter-individual variation in transcriptional response is predictive of in vitro ce...
The currently available techniques for the safety evaluation of candidate drugs are usually cost-int...
Doxorubicin (DOX), a widely used anticancer agent, can cause an unpredictable cardiac toxicity which...
Resumen del póster presentado al XXXIX Congreso de la Sociedad Española de Bioquímica y Biología Mol...
Anthracycline-induced cardiotoxicity (ACT) is a key limiting factor in setting optimal chemotherapy ...
Anthracycline-induced cardiotoxicity (ACT) is a key limiting factor in setting optimal chemotherapy ...
Anthracycline-induced cardiotoxicity (ACT) is a key limiting factor in setting optimal chemotherapy ...
Anthracyclines, such as doxorubicin, are highly efficient chemotherapeutic agents against a variety ...
Anthracyclines, such as doxorubicin, are highly efficient chemotherapeutic agents against a variety ...
Anthracyclines, such as doxorubicin, are highly efficient chemotherapeutic agents against a variety ...
Anthracyclines, such as doxorubicin, are highly efficient chemotherapeutic agents against a variety ...
Cardiotoxicity due to anthracyclines (CDA) affects cancer patients, but we cannot predict who may su...
Background: Despite known clinical risk factors, predicting anthracycline cardiotoxicity remains cha...
Background: Anthracyclines, such as doxorubicin (Adriamycin), are highly effective chemotherapeutic ...
Aims: Doxorubicin (DOX), a widely used anticancer agent, can cause an unpredictable cardiac toxicity...
The currently available techniques for the safety evaluation of candidate drugs are usually cost-int...
The currently available techniques for the safety evaluation of candidate drugs are usually cost-int...
Doxorubicin (DOX), a widely used anticancer agent, can cause an unpredictable cardiac toxicity which...
Resumen del póster presentado al XXXIX Congreso de la Sociedad Española de Bioquímica y Biología Mol...
Anthracycline-induced cardiotoxicity (ACT) is a key limiting factor in setting optimal chemotherapy ...
Anthracycline-induced cardiotoxicity (ACT) is a key limiting factor in setting optimal chemotherapy ...
Anthracycline-induced cardiotoxicity (ACT) is a key limiting factor in setting optimal chemotherapy ...
Anthracyclines, such as doxorubicin, are highly efficient chemotherapeutic agents against a variety ...
Anthracyclines, such as doxorubicin, are highly efficient chemotherapeutic agents against a variety ...
Anthracyclines, such as doxorubicin, are highly efficient chemotherapeutic agents against a variety ...
Anthracyclines, such as doxorubicin, are highly efficient chemotherapeutic agents against a variety ...
Cardiotoxicity due to anthracyclines (CDA) affects cancer patients, but we cannot predict who may su...
Background: Despite known clinical risk factors, predicting anthracycline cardiotoxicity remains cha...
Background: Anthracyclines, such as doxorubicin (Adriamycin), are highly effective chemotherapeutic ...
Aims: Doxorubicin (DOX), a widely used anticancer agent, can cause an unpredictable cardiac toxicity...
The currently available techniques for the safety evaluation of candidate drugs are usually cost-int...
The currently available techniques for the safety evaluation of candidate drugs are usually cost-int...
Doxorubicin (DOX), a widely used anticancer agent, can cause an unpredictable cardiac toxicity which...
Resumen del póster presentado al XXXIX Congreso de la Sociedad Española de Bioquímica y Biología Mol...